Bristol Myers Squibb (BMY) Assets Average (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Assets Average for 17 consecutive years, with $87.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average fell 6.94% year-over-year to $87.1 billion in Q2 2026; TTM through Jun 2026 was $87.1 billion, a 6.94% decrease from a year earlier, with the FY2025 full-year figure at $91.3 billion, down 2.73% from the prior year.
• Assets Average was $87.1 billion for Q2 2026 at Bristol Myers Squibb, down from $88.3 billion in the prior quarter.
• Over five years, Assets Average peaked at $106.2 billion in Q1 2022 and troughed at $87.1 billion in Q2 2026.
• A 5-year average of $95.1 billion and a median of $94.0 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average retreated 11.44% in 2022 and advanced 3.15% in 2024, its largest moves.
• Over 5 years, Assets Average stood at $97.5 billion in 2022, then fell by 4.41% to $93.2 billion in 2023, then declined by 0.08% to $93.1 billion in 2024, then climbed by 0.35% to $93.5 billion in 2025, then decreased by 6.86% to $87.1 billion in 2026.
• The last three Assets Average figures came in at $87.1 billion (Q2 2026), $88.3 billion (Q1 2026), and $93.5 billion (Q4 2025), per Business Quant data.